In patients with chronic obstructive pulmonary disease (COPD), the microbiome analysis revealed a reduction in microbial diversity associated with remodelling of the alveolar and bronchiolar tissue, the infiltration of CD4+ T-cells, and emphysematous destruction. This evidence concerns the gene CD4 and chronic obstructive pulmonary disease.